Financial Information of Suraksha Diagnostic Limited IPO
The Revenues from operations for the Three Months of September 30, 2024, Fiscals 2024, 2023 and 2022 were ₹618.49 Million, ₹2,222.60 Million, ₹1,936.87 Million and ₹2,257.68 Million, respectively. The EBITDA for the Three Months of September 30, 2024, Fiscals 2024, 2023 and 2022 were ₹217.21 Million, ₹728.39 Million, ₹474.79 Million and ₹652.53 Million, respectively. The Profit after Tax for the Three Months of September 30, 2024, Fiscals 2024, 2023 and 2022 was ₹76.67 Million, ₹231.27 Million, ₹60.65 Million and ₹208.24 Million, respectively.
| Period Ended | June 30, 2024 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
|---|---|---|---|---|
| Reserve of Surplus | 1,767.96 | 1,708.79 | 1,473.97 | 1,373.13 |
| Total Assets | 3,141.99 | 3,002.07 | 2,811.95 | 2,759.59 |
| Total Borrowings | 1,275.82 | 1,210.60 | 1,257.34 | 1,301.31 |
| Fixed Assets | 1,365.33 | 1,350.50 | 1,127.89 | 1,175.54 |
| Cash | 44.21 | 25.20 | 21.62 | 31.89 |
| Net Borrowing | 1,231.61 | 1,185.40 | 1,235.72 | 1,269.42 |
| Revenue | 618.49 | 2,222.60 | 1,936.87 | 2,257.68 |
| EBITDA | 217.21 | 728.39 | 474.79 | 652.53 |
| PAT | 76.67 | 231.27 | 60.65 | 208.24 |
| EPS | 1.49 | 4.43 | 1.22 | 3.91 |
Note 1:- RoE & ROCE calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit for the Year) on 31st Mar, 2024 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on Cap Price after Issue, given in Financial Express.
Copyright @2020 Design & Developed by Info Web Software